CEO David Ricks got a 10% raise in 2024, as a surge in demand for weigh-loss drugs has propelled the pharma giant into the most valuable pharmaceutical company in the world.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback